{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T07:42:40Z","timestamp":1794210160889,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001843","name":"SERB","doi-asserted-by":"crossref","award":["DST-SERB (CRG\/2019\/002104), India"],"award-info":[{"award-number":["DST-SERB (CRG\/2019\/002104), India"]}],"id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["Ramalingaswami re-entry fellowship, DBT (BT\/RLF\/Re-entry\/13\/2016)"],"award-info":[{"award-number":["Ramalingaswami re-entry fellowship, DBT (BT\/RLF\/Re-entry\/13\/2016)"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1007\/s00018-022-04595-6","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T15:04:06Z","timestamp":1667055846000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":132,"title":["Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK\/mTOR\/ERK signaling"],"prefix":"10.1007","volume":"79","author":[{"given":"Rahail","family":"Ashraf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9238-2349","authenticated-orcid":false,"given":"Sanjay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"4595_CR1","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3322\/caac.21559","volume":"69","author":"S Lheureux","year":"2019","unstructured":"Lheureux S, Braunstein M, Oza AM (2019) Epithelial ovarian cancer. Evolution of management in the era of precision medicine. CA Cancer J Clin 69:280\u2013304. https:\/\/doi.org\/10.3322\/caac.21559","journal-title":"CA Cancer J Clin"},{"key":"4595_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21708","volume":"72","author":"RL Siegel","year":"2022","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A (2022) Cancer statistics. CA Cancer J Clin 72:7\u201333. https:\/\/doi.org\/10.3322\/caac.21708","journal-title":"CA Cancer J Clin"},{"key":"4595_CR3","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) SEER Cancer Statistics Review, National Cancer Institute, Bethesda, MD (1975\u20132017). https:\/\/seer.cancer.gov\/csr\/1975_2017\/ based on November 2019 SEER data submission, posted to the SEER web site, April 2020"},{"key":"4595_CR4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1200\/JCO.2008.19.1684","volume":"27","author":"MA Bookman","year":"2009","unstructured":"Bookman MA, Brady MF, McGuire WP, Harper PG, Alberts DS, Friedlander M, Colombo N, Fowler JM, Argenta PA, DeGeest K, Mutch DG, Burger RA, Swart AM, Trimble EL, Accario-Winslow C, Roth LM (2009) Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a phase III Trial of the Gynecologic Cancer Intergroup. J Clin Oncol 27:1419\u20131425. https:\/\/doi.org\/10.1200\/JCO.2008.19.1684","journal-title":"J Clin Oncol"},{"key":"4595_CR5","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/jnci\/djg036","volume":"95","author":"A du Bois","year":"2003","unstructured":"du Bois A, L\u00fcck H-J, Meier W, Adams H-P, M\u00f6bus V, Costa S, Bauknecht T, Richter B, Warm M, Schr\u00f6der W, Olbricht S, Nitz U, Jackisch C, Emons G, Wagner U, Kuhn W (2003) A randomized clinical trial of cisplatin\/paclitaxel versus carboplatin\/paclitaxel as first-line treatment of ovarian cancer. J Natl Cancer Inst 95:1320\u20131329. https:\/\/doi.org\/10.1093\/jnci\/djg036","journal-title":"J Natl Cancer Inst"},{"key":"4595_CR6","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, Mannel RS, DeGeest K, Hartenbach EM, Baergen R (2003) Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol 21:3194\u20133200. https:\/\/doi.org\/10.1200\/JCO.2003.02.153","journal-title":"J Clin Oncol"},{"key":"4595_CR7","doi-asserted-by":"publisher","first-page":"16061","DOI":"10.1038\/nrdp.2016.62","volume":"2","author":"UA Matulonis","year":"2016","unstructured":"Matulonis UA, Sood AK, Fallowfield L, Howitt BE, Sehouli J, Karlan BY (2016) Ovarian cancer. Nat Rev Dis Primers 2:16061. https:\/\/doi.org\/10.1038\/nrdp.2016.62","journal-title":"Nat Rev Dis Primers"},{"key":"4595_CR8","doi-asserted-by":"publisher","unstructured":"Drew Y, Kaufman B, Banerjee S, Lortholary A, Hong SH, Park YH, Zimmermann S, Roxburgh P, Ferguson M, Alvarez RH, Domchek S, Gresty C, Gresty C, Angell HK, Ros VR, Meyer K, Lanasa M, Herbolsheimer P, de Jonge (2019) M1190PD-Phase II study of olaparib + durvalumab (MEDIOLA): updated results in germline BRCA-mutated platinum-sensitive relapsed (PSR) ovarian cancer (OC). Ann Oncol 30(5):v485\u2013v486. https:\/\/doi.org\/10.1093\/annonc\/mdz253.016","DOI":"10.1093\/annonc\/mdz253.016"},{"key":"4595_CR9","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.1016\/S0140-6736(17)32440-6","volume":"390","author":"RL Coleman","year":"2017","unstructured":"Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O\u2019Malley DM, Armstrong DK, Garcia-Donas Jesus ulfovich MV (2017) Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 390:1949\u20131961. https:\/\/doi.org\/10.1016\/S0140-6736(17)32440-6","journal-title":"Lancet"},{"issue":"6098","key":"4595_CR10","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1126\/science.1219855","volume":"337","author":"RJ Youle","year":"2012","unstructured":"Youle RJ, Van Der Bliek AM (2012) Mitochondrial fission, fusion, and stress. Science 337(6098):1062\u20131065. https:\/\/doi.org\/10.1126\/science.1219855","journal-title":"Science"},{"key":"4595_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.600113","volume":"10","author":"JP Greico","year":"2021","unstructured":"Greico JP, Allen ME, Perry JB, Wang Y, Song Y, Rohani A, Compton SLE, Smyth JW, Swami NS, Brown DA, Schmelz EM (2021) Progression-mediated changes in mitochondrial morphology promotes adaptation to hypoxic peritoneal conditions in serous ovarian cancer. Front Oncol 10:600113. https:\/\/doi.org\/10.3389\/fonc.2020.600113","journal-title":"Front Oncol"},{"issue":"3","key":"4595_CR12","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","volume":"177","author":"E Lengyel","year":"2010","unstructured":"Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053\u20131064. https:\/\/doi.org\/10.2353\/ajpath.2010.100105","journal-title":"Am J Pathol"},{"key":"4595_CR13","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1056\/NEJMra1215233","volume":"369","author":"SL Archer","year":"2013","unstructured":"Archer SL (2013) Mitochondrial dynamics-mitochondrial fission and fusion in human diseases. N Engl J Med 369:2236\u20132251. https:\/\/doi.org\/10.1056\/NEJMra1215233","journal-title":"N Engl J Med"},{"key":"4595_CR14","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1038\/s41467-018-04033-x","volume":"9","author":"GR Anderson","year":"2018","unstructured":"Anderson GR, Wardell SE, Cakir M, Yip C, Ahn Y-R, Ali M, Yllanes AP, Chao CA, McDonnell DP, Wood KC (2018) Dysregulation of mitochondrial dynamics proteins are a targetable feature of human tumors. Nat Commun 9:1677. https:\/\/doi.org\/10.1038\/s41467-018-04033-x","journal-title":"Nat Commun"},{"key":"4595_CR15","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.ebiom.2018.07.026","volume":"34","author":"C Kingnate","year":"2018","unstructured":"Kingnate C, Charoenkwan K, Kumfu S, Chattipakorn N, Chattipakorn SC (2018) Possible roles of mitochondrial dynamics and the effects of pharmacological interventions in chemoresistant ovarian cancer. EBioMedicine 34:256\u2013266. https:\/\/doi.org\/10.1016\/j.ebiom.2018.07.026","journal-title":"EBioMedicine"},{"key":"4595_CR16","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1038\/s41598-021-81469-0","volume":"11","author":"MH You","year":"2021","unstructured":"You MH, Jeon MJ, Kim SR, Lee WK, Cheng S-Y, Jang G, Kim TY, Kim WB, Shong YK, Kim WG (2021) Mitofusin-2 modulates the epithelial to mesenchymal transition in thyroid cancer progression. Sci Rep 11:2054. https:\/\/doi.org\/10.1038\/s41598-021-81469-0","journal-title":"Sci Rep"},{"issue":"3","key":"4595_CR17","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.3892\/ol.2019.10570","volume":"18","author":"G Pang","year":"2019","unstructured":"Pang G, Xie Q, Yao J (2019) Mitofusin 2 inhibits bladder cancer cell proliferation and invasion via the Wnt\/\u03b2-catenin pathway. Oncol Lett 18(3):2434\u20132442. https:\/\/doi.org\/10.3892\/ol.2019.10570","journal-title":"Oncol Lett"},{"key":"4595_CR18","doi-asserted-by":"publisher","first-page":"41718","DOI":"10.1038\/srep41718","volume":"7","author":"K Xu","year":"2017","unstructured":"Xu K, Chen G, Li X, Wu X, Chang Z, Xu J, Zhu Y, Yin P, Liang X, Dong L (2017) MFN2 suppresses cancer progression through inhibition of mTORC2\/Akt signaling. Sci Rep 7:41718. https:\/\/doi.org\/10.1038\/srep41718","journal-title":"Sci Rep"},{"issue":"15_suppl","key":"4595_CR19","doi-asserted-by":"publisher","first-page":"e13007","DOI":"10.1200\/JCO.2017.35.15_suppl.e13007","volume":"35","author":"Y Lou","year":"2017","unstructured":"Lou Y, Zhang Y, Xu J, Gu P, Zhang W, Zhang X, Zhong H, Jiang L, Han B (2017) MFN2 might be a risk factor for lung adenocarcinoma. J Clinic Oncol 35(15_suppl):e13007\u2013e13007. https:\/\/doi.org\/10.1200\/JCO.2017.35.15_suppl.e13007","journal-title":"J Clinic Oncol"},{"issue":"16","key":"4595_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.126915","volume":"5","author":"M Yu","year":"2019","unstructured":"Yu M, Nguyen ND, Huang Y, Lin D, Fujimoto TN, Molkentine JM, Deorukhkar A, Kang Y, Lucas FAS, Fernandes CJ, Koay EJ, Gupta S, Ying H, Koong AC, Herman JM, Fleming JB, Maitra A, Taniguchi CM (2019) Mitochondrial fusion exploits a therapeutic vulnerability of pancreatic cancer. JCI Insight 5(16):e126915. https:\/\/doi.org\/10.1172\/jci.insight.126915","journal-title":"JCI Insight"},{"key":"4595_CR21","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.4161\/auto.25399","volume":"9","author":"AD Garg","year":"2013","unstructured":"Garg AD, Dudek AM, Ferreira GB, Verfaillie T, Vandenabeele P, Krysko DV, Mathieu C, Agostinis P (2013) ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death. Autophagy 9:1292\u20131307. https:\/\/doi.org\/10.4161\/auto.25399","journal-title":"Autophagy"},{"issue":"6","key":"4595_CR22","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1080\/15548627.2016.1166318","volume":"12","author":"Q Huang","year":"2016","unstructured":"Huang Q, Zhan L, Cao H, Li J, Lyu Y, Guo X, Zhang J, Ji L, Ren T, An J, Liu B, Nie Y, Xing J (2016) Increased mitochondrial fission promotes autophagy and hepatocellular carcinoma cell survival through the ROS-modulated coordinated regulation of the NFKB and TP53 pathways. Autophagy 12(6):999\u20131014. https:\/\/doi.org\/10.1080\/15548627.2016.1166318","journal-title":"Autophagy"},{"key":"4595_CR23","doi-asserted-by":"publisher","first-page":"8794612","DOI":"10.1155\/2019\/8794612","volume":"2019","author":"M Cordani","year":"2019","unstructured":"Cordani M, Donadelli M, Strippoli R, Bazhin AV, S\u00e1nchez-\u00c1lvarez M (2019) Interplay between ROS and autophagy in cancer and aging: from molecular mechanisms to novel therapeutic approaches. Oxid Med Cell Longev 2019:8794612. https:\/\/doi.org\/10.1155\/2019\/8794612","journal-title":"Oxid Med Cell Longev"},{"key":"4595_CR24","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.redox.2014.12.003","volume":"4","author":"L Poillet-Perez","year":"2015","unstructured":"Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M (2015) Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol 4:184\u2013192. https:\/\/doi.org\/10.1016\/j.redox.2014.12.003","journal-title":"Redox Biol"},{"issue":"5","key":"4595_CR25","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3109\/10715761003667554","volume":"44","author":"G-H Liou","year":"2010","unstructured":"Liou G-H, Storz P (2010) Reactive oxygen species in cancer. Free Radic Res 44(5):10. https:\/\/doi.org\/10.3109\/10715761003667554","journal-title":"Free Radic Res"},{"issue":"4","key":"4595_CR26","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3892\/ijo.30.4.971","volume":"30","author":"KB Reddy","year":"2007","unstructured":"Reddy KB, Glaros S (2007) Inhibition of the MAP kinase activity suppresses estrogen-induced breast tumor growth both in vitro and in vivo. Int J Oncol 30(4):971\u2013975. https:\/\/doi.org\/10.3892\/ijo.30.4.971","journal-title":"Int J Oncol"},{"issue":"10","key":"4595_CR27","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.freeradbiomed.2006.08.003","volume":"41","author":"LZ Liu","year":"2006","unstructured":"Liu LZ, Hu X-W, Xia C, He J, Zhou Q, Shi X, Fang J, Jiang B-H (2006) Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells. Free Radic Biol Med 41(10):1521\u20131533. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2006.08.003","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"4595_CR28","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3892\/ol.2013.1403","volume":"6","author":"B Yi","year":"2013","unstructured":"Yi B, Liu D, He M, Li Q, Liu T, Shao J (2013) Role of the ROS\/AMPK signaling pathway in tetramethylpyrazine-induced apoptosis in gastric cancer cells. Oncol Lett 6(2):583\u2013589. https:\/\/doi.org\/10.3892\/ol.2013.1403","journal-title":"Oncol Lett"},{"issue":"37","key":"4595_CR29","doi-asserted-by":"publisher","first-page":"60021","DOI":"10.18632\/oncotarget.11047","volume":"7","author":"DK Tanwar","year":"2016","unstructured":"Tanwar DK, Parker DJ, Gupta P (2016) Crosstalk between the mitochondrial fission protein, Drp1, and the cell cycle is identified across various cancer types and can impact the survival of epithelial ovarian cancer patients. Oncotarget 7(37):60021\u201360037. https:\/\/doi.org\/10.18632\/oncotarget.11047","journal-title":"Oncotarget"},{"issue":"4","key":"4595_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.molcel.2016.04.010","volume":"62","author":"S Kumar","year":"2016","unstructured":"Kumar S, Pan CC, Shah N, Wheeler SE, Hoyt KR, Hempel N, Mythreye K, Lee NY (2016) Activation of mitofusin2 by Smad2-RIN1 complex during mitochondrial fusion. Mol Cell 62(4):520\u2013531. https:\/\/doi.org\/10.1016\/j.molcel.2016.04.010","journal-title":"Mol Cell"},{"issue":"2","key":"4595_CR31","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/j.jid.2016.11.020","volume":"137","author":"A Grada","year":"2017","unstructured":"Grada A, Otero-Vinas A, Prieto-Castrillo F, Obagi Z, Falanga V (2017) Research techniques made simple: analysis of collective cell migration using the wound healing assay. J Investig Dermatol 137(2):e11\u2013e16. https:\/\/doi.org\/10.1016\/j.jid.2016.11.020","journal-title":"J Investig Dermatol"},{"issue":"3","key":"4595_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.chembiol.2017.12.001","volume":"25","author":"L Miret-Casals","year":"2018","unstructured":"Miret-Casals L, Sebasti\u00e1n D, Brea J, Rico-Leo EM, Palac\u00edn M, Fern\u00e1ndez-Salguero PM, Loza MI, Albericio F, Zorzano A (2018) Identification of new activators of mitochondrial fusion reveals a link between mitochondrial morphology and pyrimidine metabolism. Cell Chem Biol 25(3):268-278.e4. https:\/\/doi.org\/10.1016\/j.chembiol.2017.12.001","journal-title":"Cell Chem Biol"},{"key":"4595_CR33","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1038\/cdd.2012.18","volume":"19","author":"J Grohm","year":"2012","unstructured":"Grohm J, Kim S-W, Mamrak U, Tobaben S, Cassidy-Stone A, Nunnari J, Plesnila N, Culmsee C (2012) Inhibition of Drp1 provides neuroprotection in vitro and in vivo. Cell Death Differ 19:1446\u20131458. https:\/\/doi.org\/10.1038\/cdd.2012.18","journal-title":"Cell Death Differ"},{"key":"4595_CR34","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1038\/s41416-020-0778-x","volume":"122","author":"W Dai","year":"2020","unstructured":"Dai W, Wang G, Chwa J, Oh ME, Abeywardana T, Yang Y, Wang QA, Jiang L (2020) Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer. Br J Cancer 122:1288\u20131297. https:\/\/doi.org\/10.1038\/s41416-020-0778-x","journal-title":"Br J Cancer"},{"key":"4595_CR35","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1023\/A:1006859115450","volume":"174","author":"M L\u00f6ffler","year":"1997","unstructured":"L\u00f6ffler M, J\u00f6ckel J, Schuster G (1997) Dihydroorotat-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides. Mol Cell Biochem 174:125\u2013129. https:\/\/doi.org\/10.1023\/A:1006859115450","journal-title":"Mol Cell Biochem"},{"issue":"8","key":"4595_CR36","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/genes9080416","volume":"9","author":"D Slade","year":"2018","unstructured":"Slade D (2018) Maneuvers on PCNA rings during DNA replication and repair. Genes (Basel) 9(8):416. https:\/\/doi.org\/10.3390\/genes9080416","journal-title":"Genes (Basel)"},{"key":"4595_CR37","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/s09680004(00)89005-2","volume":"20","author":"CJ Sherr","year":"1995","unstructured":"Sherr CJ (1995) D-Type cyclins. Trends Biochem Sci 20:187\u2013190. https:\/\/doi.org\/10.1016\/s09680004(00)89005-2","journal-title":"Trends Biochem Sci"},{"issue":"9","key":"4595_CR38","doi-asserted-by":"publisher","first-page":"3780","DOI":"10.1158\/0008-5472.CAN-09-4439","volume":"70","author":"J Shankar","year":"2010","unstructured":"Shankar J, Messenberg A, Chan J, Underhill TM, Foster LJ, Nabi IR (2010) Pseudopodial actin dynamics control epithelial-mesenchymal transition in metastatic cancer cells. Cancer Res 70(9):3780\u20133790. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-4439","journal-title":"Cancer Res"},{"key":"4595_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1006\/scbi.2000.0363","volume":"11","author":"JS Condeelis","year":"2001","unstructured":"Condeelis JS, Wyckoff JB, Bailly M, Pestell R, Lawrence D, Backer J, Segall JE (2001) Lamellipodia in the invasion. Semin Cancer Biol 11:119\u2013128. https:\/\/doi.org\/10.1006\/scbi.2000.0363","journal-title":"Semin Cancer Biol"},{"key":"4595_CR40","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","volume":"13","author":"J Kim","year":"2011","unstructured":"Kim J, Kundu M, Viollet B, Guan K-L (2011) AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13:132\u2013141. https:\/\/doi.org\/10.1038\/ncb2152","journal-title":"Nat Cell Biol"},{"key":"4595_CR41","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/s12935-019-0916-9","volume":"19","author":"X Liu","year":"2019","unstructured":"Liu X, Sun J, Yuan P, Shou K, Zhou Y, Gao W, She J, Hu J, Yang J, Yang J (2019) Mfn2 inhibits proliferation and cell-cycle in Hela cells via Ras-NF-\u03baB signal pathway. Cancer Cell Int 19:197. https:\/\/doi.org\/10.1186\/s12935-019-0916-9","journal-title":"Cancer Cell Int"},{"issue":"52","key":"4595_CR42","doi-asserted-by":"publisher","first-page":"90132","DOI":"10.18632\/oncotarget.21487","volume":"8","author":"X Wang","year":"2017","unstructured":"Wang X, Liu W, Zhuang D, Hong S, Chen J (2017) Sestrin2 and sestrin3 suppress NK-92 cell-mediated cytotoxic activity on ovarian cancer cells through AMPK and mTORC1 signaling. Oncotarget 8(52):90132\u201390143. https:\/\/doi.org\/10.18632\/oncotarget.21487","journal-title":"Oncotarget"},{"issue":"3","key":"4595_CR43","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.3892\/or.2014.3701","volume":"33","author":"J-L Wei","year":"2015","unstructured":"Wei J-L, Fu Z-X, Fang M, Guo J-B, Zhao Q-N, Lu W-D, Zhou Q-Y (2015) Decreased expression of sestrin 2 predicts unfavorable outcome in colorectal cancer. Oncol Rep 33(3):1349\u20131357. https:\/\/doi.org\/10.3892\/or.2014.3701","journal-title":"Oncol Rep"},{"issue":"30","key":"4595_CR44","doi-asserted-by":"publisher","first-page":"49318","DOI":"10.18632\/oncotarget.17595","volume":"8","author":"J-L Wei","year":"2017","unstructured":"Wei J-L, Fang M, Fu ZX, Zhang S-R, Guo J-B, Wang R, Lv Z-B, Xiong Y-F (2017) Sestrin 2 suppresses cells proliferation through AMPK\/mTORC1 pathway activation in colorectal cancer. Oncotarget 8(30):49318\u201349328. https:\/\/doi.org\/10.18632\/oncotarget.17595","journal-title":"Oncotarget"},{"key":"4595_CR45","doi-asserted-by":"publisher","first-page":"17024","DOI":"10.1038\/cddiscovery.2017.24","volume":"3","author":"E Ebnoether","year":"2017","unstructured":"Ebnoether E, Ramseier A, Cortada M, Bodmer D, Levano-Huaman S (2017) Sesn2 gene ablation enhances susceptibility to gentamicin-induced hair cell death via modulation of AMPK\/mTOR signaling. Cell Death Discov 3:17024. https:\/\/doi.org\/10.1038\/cddiscovery.2017.24","journal-title":"Cell Death Discov"},{"issue":"8","key":"4595_CR46","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41416-018-0288-2","volume":"119","author":"M Cordani","year":"2018","unstructured":"Cordani M, Butera G, Dando I, Torrens-Mas M, Butturini E, Pacchiana R et al (2018) Mutant p53 blocks SESN1\/AMPK\/PGC-1\u03b1\/UCP2 axis increasing mitochondrial O2\u02c9\u00b7 production in cancer cells. Br J Cancer 119(8):994\u20131008. https:\/\/doi.org\/10.1038\/s41416-018-0288-2","journal-title":"Br J Cancer"},{"key":"4595_CR47","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1038\/emboj.2013.168","volume":"32","author":"JP Mu\u00f1oz","year":"2013","unstructured":"Mu\u00f1oz JP, Ivanova S, S\u00e1nchez-Wandelmer J, Mart\u00ednez-Crist\u00f3bal P, Noguera E, Sancho A, D\u00edaz-Ramos A, Hern\u00e1ndez-Alvarez MI, Sebasti\u00e1n D, Mauvezin C, Palac\u00edn M, Zorzano A (2013) Mfn2 modulates the UPR and mitochondrial function via repression of PERK. EMBO J 32:2348\u20132361. https:\/\/doi.org\/10.1038\/emboj.2013.168","journal-title":"EMBO J"},{"issue":"24","key":"4595_CR48","doi-asserted-by":"publisher","first-page":"7358","DOI":"10.7150\/jca.61379","volume":"12","author":"G-P Zou","year":"2021","unstructured":"Zou G-P, Yu C-X, Shi S-L, Li Q-G, Wang X-H, Qu X-H, Yang Z-J, Yao W-R, Yan D-D, Jiang L-P, Wan Y-Y, Han X-J (2021) Mitochondrial dynamics mediated by DRP1 and MFN2 contributes to cisplatin chemoresistance in human ovarian cancer SKOV3 cells. J Cancer 12(24):7358\u20137373. https:\/\/doi.org\/10.7150\/jca.61379","journal-title":"J Cancer"},{"issue":"2","key":"4595_CR49","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1530\/ERC-11-0329","volume":"19","author":"B Gyorffy","year":"2012","unstructured":"Gyorffy B, Lanczky A, Szallasi Z (2012) Implementing an online tool for genome-wide validation of survival-associated biomarkers in ovarian cancer using microarray data of 1287 patients. Endocr Relat Cancer 19(2):197\u2013208. https:\/\/doi.org\/10.1530\/ERC-11-0329","journal-title":"Endocr Relat Cancer"},{"key":"4595_CR50","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1038\/ncomms3789","volume":"4","author":"H Abeliovich","year":"2013","unstructured":"Abeliovich H, Zarei M, Rigbolt KT, Youle RJ, Dengjel J (2013) Involvement of mitochondrial dynamics in the segregation of mitochondrial matrix proteins during stationary phase mitophagy. Nat Commun 4:2789. https:\/\/doi.org\/10.1038\/ncomms3789","journal-title":"Nat Commun"},{"issue":"1","key":"4595_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s10059-013-0140-8","volume":"36","author":"SW Ryter","year":"2013","unstructured":"Ryter SW, Cloonan SM, Choi AMK (2013) Autophagy: a critical regulator of cellular metabolism and homeostasis. Mol Cells 36(1):7\u201316. https:\/\/doi.org\/10.1007\/s10059-013-0140-8","journal-title":"Mol Cells"},{"issue":"5","key":"4595_CR52","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3892\/or.2014.3448","volume":"32","author":"Y Wan","year":"2014","unstructured":"Wan Y, Ma J, Shen H, Wang C, Sun Y, Howell SB, Lin X (2014) Reactive oxygen species promote ovarian cancer progression via the HIF-1\u03b1\/LOX\/E-cadherin pathway. Oncol Rep 32(5):2150\u20132158. https:\/\/doi.org\/10.3892\/or.2014.3448","journal-title":"Oncol Rep"},{"issue":"7","key":"4595_CR53","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.7150\/jca.17986","volume":"8","author":"C-L Fang","year":"2017","unstructured":"Fang C-L, Sun D-P, Chen H-K, Lin C-C, Hung S-T, Uen YH, Lin KY (2017) Overexpression of mitochondrial GTPase MFN2 represents a negative prognostic marker in human gastric cancer, and its inhibition exerts anti-cancer effects. J Cancer 8(7):1153\u20131161. https:\/\/doi.org\/10.7150\/jca.17986","journal-title":"J Cancer"},{"key":"4595_CR54","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.21873\/anticanres.12610","volume":"38","author":"SY Ahn","year":"2018","unstructured":"Ahn SY, Li C, Zhang X, Hyun Y-M (2018) Mitofusin-2 expression is implicated in cervical cancer pathogenesis. Anticancer Res 38:3419\u20133426. https:\/\/doi.org\/10.21873\/anticanres.12610","journal-title":"Anticancer Res"},{"key":"4595_CR55","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13048-017-0356-x","volume":"10","author":"R Zhang","year":"2017","unstructured":"Zhang R, Shi H, Ren F, Zhang M, Ji P, Wang W, Liu C (2017) The aberrant upstream pathway regulations of CDK1 protein were implicated in the proliferation and apoptosis of ovarian cancer cells. J Ovarian Res 10:60. https:\/\/doi.org\/10.1186\/s13048-017-0356-x","journal-title":"J Ovarian Res"},{"issue":"50","key":"4595_CR56","doi-asserted-by":"publisher","first-page":"83476","DOI":"10.18632\/oncotarget.13080","volume":"7","author":"L Zhan","year":"2016","unstructured":"Zhan L, Zhang Y, Wang W, Song E, Fan Y, Li J, Wei B (2016) Autophagy as an emerging therapy target for ovarian carcinoma. Oncotarget 7(50):83476\u201383487. https:\/\/doi.org\/10.18632\/oncotarget.13080","journal-title":"Oncotarget"},{"issue":"1","key":"4595_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1146\/annurev-genet-102808-114910","volume":"43","author":"C He","year":"2009","unstructured":"He C, Klionsky D (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43(1):67\u201393. https:\/\/doi.org\/10.1146\/annurev-genet-102808-114910","journal-title":"Annu Rev Genet"},{"key":"4595_CR58","doi-asserted-by":"publisher","first-page":"2798070","DOI":"10.1155\/2018\/2798070","volume":"2018","author":"R Xue","year":"2018","unstructured":"Xue R, Meng Q, Lu D, Liu X, Wang Y, Hao J (2018) Mitofusin2 induces cell autophagy of pancreatic cancer through inhibiting the PI3K\/Akt\/mTOR signaling pathway. Oxid Med Cell Longev 2018:2798070. https:\/\/doi.org\/10.1155\/2018\/2798070","journal-title":"Oxid Med Cell Longev"},{"key":"4595_CR59","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.tcb.2015.07.012","volume":"25","author":"X Ye","year":"2015","unstructured":"Ye X, Weinberg RA (2015) Epithelial-mesenchymal plasticity: a central regulator of cancer progression. Trends Cell Biol 25:675\u2013686. https:\/\/doi.org\/10.1016\/j.tcb.2015.07.012","journal-title":"Trends Cell Biol"},{"key":"4595_CR60","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.cmet.2018.11.004","volume":"29","author":"M-J Wu","year":"2019","unstructured":"Wu M-J, Chen Y-S, Kim MR, Chang C-C, Gampala S, Zhang Y, Wang Y, Chang C-Y, Yang J-Y, Chang C-J (2019) Epithelial-mesenchymal transition directs stem cell polarity via regulation of mitofusin. Cell Metab 29:993-1002.e1006. https:\/\/doi.org\/10.1016\/j.cmet.2018.11.004","journal-title":"Cell Metab"},{"key":"4595_CR61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0119954","volume":"10","author":"J Shankar","year":"2015","unstructured":"Shankar J, Nabi IR (2015) Actin cytoskeleton regulation of epithelial-mesenchymal transition in metastatic cancer cells. PLoS ONE 10:e0119954. https:\/\/doi.org\/10.1371\/journal.pone.0119954","journal-title":"PLoS ONE"},{"issue":"6","key":"4595_CR62","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1002\/hep.29678","volume":"67","author":"JM Peng","year":"2018","unstructured":"Peng JM, Bera R, Chiou CY, Yu MC, Chen TC, Chen CW, Wang TR, Chiang WL, Chai SP, Wei Y, Wang H, Hung MC, Hsieh SY (2018) Actin cytoskeleton remodeling drives epithelial-mesenchymal transition for hepatoma invasion and metastasis in mice. Hepatology 67(6):2226\u20132243. https:\/\/doi.org\/10.1002\/hep.29678","journal-title":"Hepatology"},{"issue":"40","key":"4595_CR63","doi-asserted-by":"publisher","first-page":"4814","DOI":"10.1038\/onc.2012.494","volume":"32","author":"J Zhao","year":"2013","unstructured":"Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, Abel PW, Tu Y (2013) Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 32(40):4814\u20134824. https:\/\/doi.org\/10.1038\/onc.2012.494","journal-title":"Oncogene"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04595-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-022-04595-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-022-04595-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T11:15:53Z","timestamp":1669720553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-022-04595-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":63,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["4595"],"URL":"https:\/\/doi.org\/10.1007\/s00018-022-04595-6","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"25 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no commercial or other competing interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"573"}}